Online Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

64 * ! Mon, 8/9/2021, 10:00 AM - 11:50 AM Virtual
Innovative Practical Improvements in Biomarker Development and Evaluation — Invited Papers
Section on Medical Devices and Diagnostics, Biometrics Section, Biopharmaceutical Section, Caucus for Women in Statistics
Organizer(s): Laura Yee, National Cancer Institute, National Institutes of Health
Chair(s): Hari Sankaran, National Cancer Institute, National Institutes of Health
10:05 AM Emulating a Target Trial to Evaluate the Clinical Utility of a Biomarker-Based Treatment Rule
Michael Charles Sachs, Karolinska Institutet
10:25 AM Two-Stage Adaptive Design for Prognostic Biomarker Signatures with a Survival Endpoint
Mei-Yin C Polley, University of Chicago; Biyue Dai, University of Iowa
10:45 AM Biologically Informed Development of Treatment Selection Scores from High-Dimensional Omics Data
Lisa McShane, National Cancer Institute
11:05 AM Sample Size Methods for Validation of Predictive Biomarkers
Kevin K Dobbin, University of Georgia; Lisa McShane, National Cancer Institute
11:25 AM Discussant: Ana Best, National Cancer Institute, National Institutes of Health
11:45 AM Floor Discussion